These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 22868838)
21. Your Name Is On The Bottle. Switalski JD Pa Dent J (Harrisb); 2017 Mar; 84(2):26. PubMed ID: 30351619 [No Abstract] [Full Text] [Related]
22. Safety plan for opioids meets resistance: opioid-linked deaths continue to soar. Kuehn BM JAMA; 2010 Feb; 303(6):495-7. PubMed ID: 20145218 [No Abstract] [Full Text] [Related]
23. Containing the opioid overdose epidemic. McCarthy M BMJ; 2012 Dec; 345():e8340. PubMed ID: 23241432 [No Abstract] [Full Text] [Related]
24. Reducing opioid. analgesic abuse: models for successful collaboration among government, industry and other key stakeholders. Smith MY; Kleber HD; Katz N; Houck LK; Sabo A Drug Alcohol Depend; 2008 May; 95(1-2):177-81. PubMed ID: 18484109 [No Abstract] [Full Text] [Related]
25. The Joint Commission and the FDA take steps to curb adverse events related to the use and misuse of opioid drugs. ED Manag; 2012 Oct; 24(10):112-6. PubMed ID: 23045763 [TBL] [Abstract][Full Text] [Related]
26. Addressing prescription opioid overdose: data support a comprehensive policy approach. Jones CM; Lurie P; Woodcock J JAMA; 2014 Nov; 312(17):1733-4. PubMed ID: 25275855 [No Abstract] [Full Text] [Related]
27. FDA to tighten labeling on long acting opioids. McCarthy M BMJ; 2013 Sep; 347():f5581. PubMed ID: 24030791 [No Abstract] [Full Text] [Related]
29. Medical education companies got $170m in grants from 14 drug firms in 2010, study finds. Kmietowicz Z BMJ; 2013 Dec; 347():f7534. PubMed ID: 24353103 [No Abstract] [Full Text] [Related]
31. Controlling the Swing of the Opioid Pendulum. Comerci G; Katzman J; Duhigg D N Engl J Med; 2018 Feb; 378(8):691-693. PubMed ID: 29466151 [No Abstract] [Full Text] [Related]
32. FDA actions to prevent prescription drug abuse. Jeske AH Tex Dent J; 2005 Jul; 122(7):634-45. PubMed ID: 16152888 [No Abstract] [Full Text] [Related]
33. The regulation of prescription drug advertising. Rheinstein RH; Hugstad PS Leg Med Annu; 1978; ():407-19. PubMed ID: 756944 [No Abstract] [Full Text] [Related]
34. Drug company sponsorship of education could be replaced at a fraction of its cost. Moynihan R BMJ; 2003 May; 326(7400):1163. PubMed ID: 12775595 [No Abstract] [Full Text] [Related]
35. ER/LA Opioid Analgesics REMS: Overview of Ongoing Assessments of Its Progress and Its Impact on Health Outcomes. Cepeda MS; Coplan PM; Kopper NW; Maziere JY; Wedin GP; Wallace LE Pain Med; 2017 Jan; 18(1):78-85. PubMed ID: 27373304 [TBL] [Abstract][Full Text] [Related]
36. Pernicious encroachment into end-of-life decision making: federal intervention in palliative pain treatment. Bolin JN Am J Bioeth; 2006; 6(5):34-6; discussion W30-2. PubMed ID: 16997822 [No Abstract] [Full Text] [Related]
37. USA homes in on prescription drug abuse. Devi S Lancet; 2011 Aug; 378(9790):473-4. PubMed ID: 21826806 [No Abstract] [Full Text] [Related]
38. REMS; red tape, or a remedy for opioid abuse? Porada S J Fam Pract; 2011 Sep; 60(9 Suppl):S55-62. PubMed ID: 22442761 [No Abstract] [Full Text] [Related]
39. Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. Volkow ND; McLellan TA JAMA; 2011 Apr; 305(13):1346-7. PubMed ID: 21467287 [No Abstract] [Full Text] [Related]